CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 44 filers reported holding CTI BIOPHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $201,000 | -67.6% | 34,578 | -66.7% | 0.00% | -100.0% |
| Q2 2022 | $620,000 | +4033.3% | 103,839 | +686.2% | 0.00% | – |
| Q2 2020 | $15,000 | -16.7% | 13,207 | -38.3% | 0.00% | – |
| Q3 2019 | $18,000 | +80.0% | 21,396 | +89.3% | 0.00% | – |
| Q2 2019 | $10,000 | -9.1% | 11,302 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | +37.5% | 11,302 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -66.7% | 11,302 | 0.0% | 0.00% | – |
| Q3 2018 | $24,000 | – | 11,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|